share_log

Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer VARKI PAUL

Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer VARKI PAUL

Avalo Therapeutics | 4:持股变动声明-高管 VARKI PAUL
美股sec公告 ·  06/25 16:12
Moomoo AI 已提取核心信息
Paul Varki, the Chief Legal Officer of Avalo Therapeutics, Inc., was involved in a transaction with the company's stock on June 24, 2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. Following the action, the updated number of shares held by Varki was also not provided. This information is crucial for investors to understand the insider activity within Avalo Therapeutics and may influence their investment decisions.
Paul Varki, the Chief Legal Officer of Avalo Therapeutics, Inc., was involved in a transaction with the company's stock on June 24, 2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. Following the action, the updated number of shares held by Varki was also not provided. This information is crucial for investors to understand the insider activity within Avalo Therapeutics and may influence their investment decisions.
2024年6月24日,Avalo Therapeutics公司的首席法律官Paul Varki参与了一项交易。公告未披露交易的具体细节,包括交易的股票数、股票性质、交易价格以及股票总价值。在此次交易后,Varki持有的股票数量也没有提供更新。这些信息对投资者了解Avalo Therapeutics内部活动至关重要,可能会影响他们的投资决策。
2024年6月24日,Avalo Therapeutics公司的首席法律官Paul Varki参与了一项交易。公告未披露交易的具体细节,包括交易的股票数、股票性质、交易价格以及股票总价值。在此次交易后,Varki持有的股票数量也没有提供更新。这些信息对投资者了解Avalo Therapeutics内部活动至关重要,可能会影响他们的投资决策。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息